First genome sequencing clinical trial for triple negative cancer points to new treatments
Thursday, December 8, 2011 - 12:32
in Health & Medicine
Initial results from an ongoing clinical trial, the first designed to examine the utility of whole-genome sequencing for triple negative breast cancer, were reported today during the CRTC-AACR San Antonio Breast Cancer Symposium.